2020
Stem Cell Therapy for Thromboangiitis Obliterans (Buerger’s Disease)
Dash B, Peyvandi H, Duan K, Richardson E, Ndon S, Gabrick K, Faz A, Persing J, Dardik A, Hsia H. Stem Cell Therapy for Thromboangiitis Obliterans (Buerger’s Disease). Processes 2020, 8: 1408. DOI: 10.3390/pr8111408.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsThromboangiitis obliteransYoung male smokersBuerger's diseaseImmunomodulatory approachesMale smokersSurgical bypassPathological findingsTreatment modalitiesVascular diseaseDefinitive cureLower extremitiesMedium arteriesLesion treatmentTherapeutic modalitiesTAO treatmentTherapeutic angiogenesisCell therapyDiseaseObliteransStem cellsCurrent knowledgeModalitiesTreatmentPotential optionVasculitis
2015
Thromboangiitis Obliterans
Tabtabai S, Beckman J. Thromboangiitis Obliterans. 2015, 3031-3041. DOI: 10.1007/978-3-642-37078-6_114.Peer-Reviewed Original ResearchRisk of amputationImprove quality of lifeCessation of smokingQuality of lifeIncidence of smokingPeriods of disease activityYoung male smokersImprove qualityMale smokersDisease activityChronic inflammationDecreased incidenceIschemic ulcersAcute thrombosisVascular insufficiencyDisease patternsSmokingSmall arteriesBuerger's diseaseThromboangiitis obliteransDisease
2014
Thromboangiitis Obliterans (Buerger’s Disease)
Tabtabai S, Beckman J. Thromboangiitis Obliterans (Buerger’s Disease). 2014, 1-12. DOI: 10.1007/978-3-642-37393-0_114-1.Peer-Reviewed Original ResearchRisk of amputationImprove quality of lifeCessation of smokingQuality of lifeIncidence of smokingPeriods of disease activityYoung male smokersImprove qualityMale smokersDisease activityChronic inflammationDecreased incidenceIschemic ulcersAcute thrombosisVascular insufficiencyDisease patternsSmokingBuerger's diseaseSmall arteriesThromboangiitis obliteransDisease
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply